Tweenvest Stocks

Theraclion SA (ENXTPA: ALTHE)

Health Care · Health Care Equipment & Supplies · FR

0.65

-3.14% today · -25.6% 1Y

Theraclion SA (ENXTPA: ALTHE) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $55.22M and employs 36 people.

Over the last twelve months the share price has lost 25.6%, trading between 0.40 and 1.25.

Tweenvest scores Theraclion SA across four factors: quality 11/100, value 65/100, growth 0/100. Its strongest factor is value.

ALTHE price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$55.22M
Revenue (TTM)
$765.53K
P/E
EPS
-0.10
Dividend yield
Beta (5Y)
0.39
52-week high
€1.25
52-week low
€0.40
Avg volume (3M)
Shares outstanding
73.11M
Employees
36
Next earnings

About Theraclion SA

Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include SONOVEIN, a robotic, non-surgical echotherapy system designed for addressing varicose veins, and ECHOPULSE, a similar robotic, non-invasive solution for treating thyroid nodules and breast fibroadenoma. Furthermore, the company provides EPack, a disposable component used during procedures to protect the patient's skin and enhance image clarity.

ISIN
FR0010120402
Founded
2004
Listed since
Apr 25, 2014
Exchange
Euronext Paris
Currency
EUR
CompanyMarket capPriceDay
Abbott LaboratoriesNYSE: ABT$201.83B$116.64+2.19%
Intuitive Surgical, Inc.NasdaqGS: ISRG$133.83B$378.81+1.19%
Stryker CorporationNYSE: SYK$126.37B$329.45+0.53%
Medtronic plcNYSE: MDT$119.49B$93.35+1.14%
EssilorLuxottica Société anonymeENXTPA: EL$87.56B163.20+1.24%
Boston Scientific CorporationNYSE: BSX$73.00B$50.37+2.03%
HOYA CorporationTSE: 7741$52.38B¥24,895.00-1.37%
Becton, Dickinson and CompanyNYSE: BDX$52.30B$192.00+2.33%

Browse every Health Care Equipment & Supplies company →

Figures last refreshed Aug 18, 2026.